Recent clinical issues related to the use of depot medroxyprogesterone acetate (Depo-Provera®)
- 1 October 1999
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Obstetrics and Gynecology
- Vol. 11 (5) , 467-471
- https://doi.org/10.1097/00001703-199910000-00009
Abstract
This report critically reviews recent original research articles concerning patient use of depot medroxyprogesterone acetate. Specifically, recent studies have been conducted on the following clinical issues: depression, galactorrhea, weight gain, bone mineral density, epithelial and mucus changes in the lower genital tract, and the acceptability of and continuation rates with the use of depot medroxyprogesterone acetate.Keywords
This publication has 23 references indexed in Scilit:
- Bone mineral density in women using depot medroxyprogesterone acetate for contraceptionObstetrics & Gynecology, 1999
- Spinal bone density in women using depot medroxyprogesterone contraception*1Obstetrics & Gynecology, 1998
- CorrespondenceJournal of Adolescent Health, 1998
- Bone density in long term users of depot medroxyprogesterone acetateBJOG: An International Journal of Obstetrics and Gynaecology, 1998
- A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptivesThe Journal of Pediatrics, 1996
- Experiences of injectable contraceptive users in an urban settingObstetrics & Gynecology, 1996
- The effectiveness of a mail reminder system for depot medroxyprogesterone injectionsArchives of Family Medicine, 1996
- Depression in users of depo-medroxyprogesterone acetateContraception, 1995
- Depo-Provera: Wherefore art thou?Adolescent and Pediatric Gynecology, 1992
- Bone density in women receiving depot medroxyprogesterone acetate for contraception.BMJ, 1991